ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies.
In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates.
In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19.
Be part of making a difference. Be part of Invivyd.
Location: Northeast Preferred
The Director, HCP and Consumer Digital Marketing is a pivotal role on the marketing team. This person will shape our online and media presence and drive digital and social media marketing strategies. This position encompasses a wide range of responsibilities, from developing and executing digital marketing strategy and campaigns to analyzing performance metrics and optimizing our online tactics.
The Director, HCP and Consumer Marketing will be responsible for developing and executing digital marketing strategies and tactics to drive and advance HCP, consumer, patient and community engagement.
This individual will shape our online presence and drive marketing strategies. This position encompasses a wide range of responsibilities, from developing and executing digital marketing campaigns to analyzing performance metrics and optimizing our online strategies.
Responsibilities:
HCP and Consumer/ Patient Digital Marketing
- Develop and implement comprehensive consumer/ patient and HCP digital marketing strategies that align with Invivyd’s goals and objectives
- Develop digital strategies, messaging, and content for disease state education for consumers/ patients that deliver against overall business objectives
- Guide and oversee tactical implementation and ongoing optimization of the EUA compliant HCP and consumer/ patient digital plans
- Develop DTC campaigns, including CTV and linear TV tactics
- Oversee HCP and consumer/ patient social media influencer tactics
- Provide agency management, including creative and media agencies
- Prioritize resource allocation, deploy resources strategically and monitor budget to ensure efficient use of resources
- Collaborate with cross-functional teams to create engaging and informative content for various digital platforms
- Oversee the execution of digital marketing campaigns, including paid advertising, SEO, email marketing, and social media initiatives
Requirements:
- Bachelor’s degree
- Minimum 5 years of pharmaceutical marketing and/or market access experience, preferably in hematology/oncology, infectious disease, transplant, vaccines, rare disease areas
- Commitment to Invivyd’s Core Values: united, determined, dynamic, proactive, spirited
- Excellent communication skills both verbal and written
- Strong preference for local candidates as in-office presence of up to 30% is required
#LI-Remote
At Invivyd we strive to create a welcoming and inclusive environment. Here all applicants will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics.
Invivyd is proud to be an equal opportunity employer.
We do not accept unsolicited resumes from agencies.
Top Skills
What We Do
Invivyd is a biopharmaceutical company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Invivyd’s technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify high-quality, long-lasting antibodies with the potential to resist viral escape. The company is generating a robust pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications. Visit https://invivyd.com/ to learn more.
